NCT03180255View on ClinicalTrials.gov

Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

July 26, 2017

Primary Completion Date

November 7, 2017

Study Completion Date

November 27, 2017

Conditions
CataractAnterior Chamber InflammationPain, Postoperative
Interventions
COMBINATION_PRODUCT

Dexamethasone phosphate

Ocular iontophoretic delivery of a steroid

OTHER

Placebo

Ocular iontophoretic delivery of a placebo

Trial Locations (1)

32204

Site 901, Jacksonville

Sponsors
All Listed Sponsors
lead

Eyegate Pharmaceuticals, Inc.

INDUSTRY